Comprehensive biomarker profiling of matched primary and metastatic estrogen receptor positive breast cancers

被引：0
|
作者：
Spoerke, Jill M. [1 ]
Schleifman, Erica B. [1 ]
Desai, Rupal [1 ]
Xiao, Yuanyuan [1 ]
Wong, Cheryl [1 ]
Abbas, Ilma [1 ]
O'Brien, Carol [1 ]
Patel, Rajesh [1 ]
Sumiyoshi, Teiko [1 ]
Fu, Ling [1 ]
Tam, Rachel [1 ]
Koeppen, Hartmut [1 ]
Wilson, Timothy [1 ]
Raja, Rajiv [1 ]
Hampton, Garret M. [1 ]
Lackner, Mark R. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
MOLECULAR CANCER RESEARCH | 2013年 / 11卷
关键词：
D O I：
10.1158/1557-3125.ADVBC-B024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B024
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
    Yau, Christina
    Benz, Christopher C.
    BREAST CANCER RESEARCH, 2008, 10 (04)
  • [32] Sex Hormone Levels and Risks of Estrogen Receptor-Negative and Estrogen Receptor-Positive Breast Cancers
    Farhat, Ghada N.
    Cummings, Steven R.
    Chlebowski, Rowan T.
    Parimi, Neeta
    Cauley, Jane A.
    Rohan, Thomas E.
    Huang, Alison J.
    Vitolins, Mara
    Hubbell, F. Allan
    Manson, JoAnn E.
    Cochrane, Barbara B.
    Lane, Dorothy S.
    Lee, Jennifer S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (07): : 562 - 570
  • [33] Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
    Christina Yau
    Christopher C Benz
    Breast Cancer Research, 10
  • [34] Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion
    Fry, Simon A.
    Robertson, Claire E.
    Swann, Ruth
    Dwek, Miriam V.
    BRITISH JOURNAL OF CANCER, 2016, 114 (09) : 1019 - 1026
  • [35] Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer
    Li, Weimin
    O'Shaughnessy, Joyce
    Hayes, Daniel
    Campone, Mario
    Bondarenko, Igor
    Zbarskaya, Irina
    Brain, Etienne
    Stenina, Marina
    Ivanova, Olga
    Graas, Marie-Pascale
    Neven, Patrick
    Ricci, Deborah
    Griffin, Thomas
    Kheoh, Thian
    Yu, Margaret
    Gormley, Michael
    Martin, Jason
    Schaffer, Michael
    Zelinsky, Kathy
    De Porre, Peter
    Johnston, Stephen R. D.
    CLINICAL CANCER RESEARCH, 2016, 22 (24) : 6002 - 6009
  • [36] Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion
    Simon A Fry
    Claire E Robertson
    Ruth Swann
    Miriam V Dwek
    British Journal of Cancer, 2016, 114 : 1019 - 1026
  • [37] Cadherin-5 is a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion
    Dwek, Miriam
    Swann, Ruth
    Robertson, Claire
    Fry, Simon
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 191 - 191
  • [38] Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion
    Gilcrease, M. Z.
    BREAST DISEASES, 2016, 27 (04): : 277 - 278
  • [39] Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers
    Weinberg, Benjamin A.
    Gowen, Kyle
    Lee, Thomas K.
    Ou, Sai-Hong Ignatius
    Bristow, Robert
    Krill, Lauren
    Almira-Suarez, M. Isabel
    Ali, Siraj M.
    Miller, Vincent A.
    Liu, Stephen V.
    Klempner, Samuel J.
    ONCOLOGIST, 2017, 22 (02): : 152 - 157
  • [40] Borderline Estrogen Receptor-Positive Breast Cancers in Black and White Women
    Benefield, Halei C.
    Allott, Emma H.
    Reeder-Hayes, Katherine E.
    Perou, Charles M.
    Carey, Lisa A.
    Geradts, Joseph
    Sun, Xuezheng
    Calhoun, Benjamin C.
    Troester, Melissa A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (07): : 728 - 736
12345